Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1955 1
1963 1
1964 1
1965 1
1966 1
1967 4
1968 1
1969 3
1970 5
1971 2
1972 6
1973 3
1974 8
1975 9
1976 7
1977 15
1978 9
1979 9
1980 8
1981 13
1982 8
1983 10
1984 3
1985 9
1986 5
1987 10
1988 11
1989 6
1990 12
1991 8
1992 7
1993 5
1994 8
1995 6
1996 9
1997 12
1998 10
1999 8
2000 14
2001 16
2002 11
2003 8
2004 6
2005 16
2006 13
2007 12
2008 10
2009 14
2010 14
2011 22
2012 23
2013 19
2014 20
2015 36
2016 25
2017 22
2018 18
2019 28
2020 29
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

617 results
Results by year
Filters applied: . Clear all
Page 1
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Yalçın Ş, Fujitani K, Beretta GD, Cutsem EV, Winkler RE, Makris L, Ilson DH, Tabernero J. Shitara K, et al. Among authors: winkler re. Lancet Oncol. 2018 Nov;19(11):1437-1448. doi: 10.1016/S1470-2045(18)30739-3. Epub 2018 Oct 21. Lancet Oncol. 2018. PMID: 30355453 Clinical Trial.
Deciphering the "m6A Code" via Antibody-Independent Quantitative Profiling.
Garcia-Campos MA, Edelheit S, Toth U, Safra M, Shachar R, Viukov S, Winkler R, Nir R, Lasman L, Brandis A, Hanna JH, Rossmanith W, Schwartz S. Garcia-Campos MA, et al. Among authors: winkler r. Cell. 2019 Jul 25;178(3):731-747.e16. doi: 10.1016/j.cell.2019.06.013. Epub 2019 Jun 27. Cell. 2019. PMID: 31257032 Free article.
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer.
Van Cutsem E, Mayer RJ, Laurent S, Winkler R, Grávalos C, Benavides M, Longo-Munoz F, Portales F, Ciardiello F, Siena S, Yamaguchi K, Muro K, Denda T, Tsuji Y, Makris L, Loehrer P, Lenz HJ, Ohtsu A; RECOURSE Study Group. Van Cutsem E, et al. Among authors: winkler r. Eur J Cancer. 2018 Feb;90:63-72. doi: 10.1016/j.ejca.2017.10.009. Epub 2017 Dec 21. Eur J Cancer. 2018. PMID: 29274618 Free PMC article. Clinical Trial.
How 'Blue' Is 'Green' Energy?
Wright AJ, Araújo-Wang C, Wang JY, Ross PS, Tougaard J, Winkler R, Márquez MC, Robertson FC, Williams KF, Reeves RR. Wright AJ, et al. Among authors: winkler r. Trends Ecol Evol. 2020 Mar;35(3):235-244. doi: 10.1016/j.tree.2019.11.002. Epub 2019 Dec 17. Trends Ecol Evol. 2020. PMID: 31862123 Review.
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
Pavel ME, Hainsworth JD, Baudin E, Peeters M, Hörsch D, Winkler RE, Klimovsky J, Lebwohl D, Jehl V, Wolin EM, Öberg K, Van Cutsem E, Yao JC; RADIANT-2 Study Group. Pavel ME, et al. Among authors: winkler re. Lancet. 2011 Dec 10;378(9808):2005-2012. doi: 10.1016/S0140-6736(11)61742-X. Epub 2011 Nov 25. Lancet. 2011. PMID: 22119496 Clinical Trial.
Three-Dimensional Nanothermistors for Thermal Probing.
Sattelkow J, Fröch JE, Winkler R, Hummel S, Schwalb C, Plank H. Sattelkow J, et al. Among authors: winkler r. ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22655-22667. doi: 10.1021/acsami.9b04497. Epub 2019 Jun 17. ACS Appl Mater Interfaces. 2019. PMID: 31154756
617 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page